| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/30/2004 | WO2004084263A2 Integrated apparatus and methods for treating liquids |
| 09/30/2004 | WO2004083942A1 Method of selecting contact lens and/or care system therefor |
| 09/30/2004 | WO2004083909A2 Fiber-optic apparatus and method for making simultaneous multiple parameter measurements |
| 09/30/2004 | WO2004083869A1 Method for evaluating antioxidation capability of organism sample |
| 09/30/2004 | WO2004083868A1 Sensor for ascorbic acid or a salt thereof |
| 09/30/2004 | WO2004083867A2 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders |
| 09/30/2004 | WO2004083866A1 Method for diagnosing lung transplantation rejection |
| 09/30/2004 | WO2004083865A2 Materials and methods for modulating cell motility |
| 09/30/2004 | WO2004083864A1 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 3 (par3) |
| 09/30/2004 | WO2004083863A1 An integrating analysis chip with minimized reactors and its application |
| 09/30/2004 | WO2004083862A1 Deglycosylated enzymes for conjugates |
| 09/30/2004 | WO2004083860A1 Blocking agent for biological molecule-immobilization support, blocking method using the same and biological molecule-detection kit comprising the same |
| 09/30/2004 | WO2004083859A1 Agglutination based sample testing device |
| 09/30/2004 | WO2004083858A1 Assessment method |
| 09/30/2004 | WO2004083857A1 Method of assaying physiological activity and apparatus |
| 09/30/2004 | WO2004083856A1 Method of detecting colon cancer marker |
| 09/30/2004 | WO2004083855A1 Method for the identification of cells specifically modulating slow inhibition in the neocortex |
| 09/30/2004 | WO2004083853A2 Test system for the discovery of substances for the promotion of neuraxonal growth |
| 09/30/2004 | WO2004083852A1 Blood cell separation membrane and blood retention tool including the same |
| 09/30/2004 | WO2004083851A2 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) |
| 09/30/2004 | WO2004083850A1 Analytical sensitivity enhancement by catalytic transformation |
| 09/30/2004 | WO2004083848A1 Gas chromatograph with fast btu analysis |
| 09/30/2004 | WO2004083843A1 Electrochemical microfluidic sensor and method of creation of its microchannels by embossing |
| 09/30/2004 | WO2004083833A1 A method and apparatus for downhole quantification of methane using near infrared spectroscopy |
| 09/30/2004 | WO2004083819A2 Molecular forensic specimen marker |
| 09/30/2004 | WO2004083818A2 Methods of identifying drug targets and modulators of neurons and compositions comprising the same |
| 09/30/2004 | WO2004083814A2 Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes |
| 09/30/2004 | WO2004083813A2 Method and apparatus for measuring concentration of a chemical component in a gas mixture |
| 09/30/2004 | WO2004083812A2 Method and apparatus for detection of contaminants in a fluid |
| 09/30/2004 | WO2004083803A2 Test methods for determining the intracellular concentration of cyclic nucleotides |
| 09/30/2004 | WO2004083778A1 Coded-light dual-view profile scanner |
| 09/30/2004 | WO2004083462A2 Replication assay for discovering antiviral substances using a high throughput screening (hts) method |
| 09/30/2004 | WO2004083455A1 Therapeutic, prophylactic and diagnostic agents |
| 09/30/2004 | WO2004083453A1 A method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling |
| 09/30/2004 | WO2004083451A1 Analysis method |
| 09/30/2004 | WO2004083449A2 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 09/30/2004 | WO2004083447A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 09/30/2004 | WO2004083436A2 Novel bt toxin receptors and methods of use |
| 09/30/2004 | WO2004083431A1 Method of screening protein capable of controlling transcription reaction and method of assaying activity thereof |
| 09/30/2004 | WO2004083429A1 Dna fragment amplification method, reaction apparatus for amplifying dna fragment and process for producing the same |
| 09/30/2004 | WO2004083422A1 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies |
| 09/30/2004 | WO2004083405A2 Separation and accumulation of subcellular components, and proteins derived therefrom |
| 09/30/2004 | WO2004083398A2 Therapeutic uses of hmgn1 and hmgn2 |
| 09/30/2004 | WO2004083394A2 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders |
| 09/30/2004 | WO2004083389A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 09/30/2004 | WO2004083385A2 Quorum sensing signaling in bacteria |
| 09/30/2004 | WO2004083374A2 Methods for screening for an antigen for use in a vaccine |
| 09/30/2004 | WO2004083370A2 Method of detecting and analysing organelles immobilised on biochips and applications thereof |
| 09/30/2004 | WO2004083366A2 Methods utilizing novel target genes related to immune-mediated diseases |
| 09/30/2004 | WO2004083241A2 Btc-interacting proteins and use thereof |
| 09/30/2004 | WO2004083175A2 Methods for identifying enzyme inhibitors and protein kinases |
| 09/30/2004 | WO2004082796A2 Systems and methods of blood-based therapies having a microfluidic membraneless exchange device |
| 09/30/2004 | WO2004082690A1 Regulation of cell surface proteins |
| 09/30/2004 | WO2004082688A1 Phosphatidylglycerol (pg) receptor agonists and antagonists |
| 09/30/2004 | WO2004082635A2 Methods and compositions related to joint inflammation diseases |
| 09/30/2004 | WO2004082627A2 ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 |
| 09/30/2004 | WO2004082617A2 Biological markers for diagnosing rheumatoid arthritis |
| 09/30/2004 | WO2004082610A2 Modulation of hyaluronan and cd44 interaction and uses thereof in treating disorders |
| 09/30/2004 | WO2004082608A2 Ligands for tgf-beta binding proteins and uses thereof |
| 09/30/2004 | WO2004082598A2 Relaxin3-gpcr135 complexes and their production and use |
| 09/30/2004 | WO2004082575A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 6b (pde6b) |
| 09/30/2004 | WO2004082574A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 09/30/2004 | WO2004082573A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4) |
| 09/30/2004 | WO2004082572A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 87 (gpr87) |
| 09/30/2004 | WO2004082571A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) |
| 09/30/2004 | WO2004082570A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2) |
| 09/30/2004 | WO2004082569A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) |
| 09/30/2004 | WO2004082568A2 Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) |
| 09/30/2004 | WO2004082567A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 09/30/2004 | WO2004082566A2 Diagnostics and therapeutics for diseases associated with complement component 3a receptor 1 (c3ar1) |
| 09/30/2004 | WO2004082517A2 Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
| 09/30/2004 | WO2004082456A2 Method for bringing into contact targetted particles and living cells in suspension |
| 09/30/2004 | WO2004082455A2 Method for detecting alzheimer’s disease and corresponding peptides and detection reagents |
| 09/30/2004 | WO2004082370A2 Cardiac-preferred genetic alteration of transgenic rabbits |
| 09/30/2004 | WO2004082363A2 Sensor assembly and methods of making and using same |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004064785A9 Cancer therapy sensitizer |
| 09/30/2004 | WO2004064768A3 Animal model for alzheimer's disease |
| 09/30/2004 | WO2004063724A8 Method of determination of anionic groups in pulp fibres |
| 09/30/2004 | WO2004062783A3 Multi-phase fluid sampling method and apparatus |
| 09/30/2004 | WO2004060295A3 Methods of inducing and maintaining immune tolerance |
| 09/30/2004 | WO2004059296A3 Device for identifying types of sheet materials |
| 09/30/2004 | WO2004059000A3 High-throughput screening method for identifying active substances by means of co-cultivation |
| 09/30/2004 | WO2004056861A3 Glycoisoforms of adiponectin and uses thereof |
| 09/30/2004 | WO2004052920A3 Conversion of apoptotic proteins |
| 09/30/2004 | WO2004048532A3 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 09/30/2004 | WO2004046355A3 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 09/30/2004 | WO2004046100A3 Release of the self-quenching of fluorescence near silver metallic surfaces |
| 09/30/2004 | WO2004045544A3 Autocrine growth factor receptor antibodies and methods |
| 09/30/2004 | WO2004043401A3 Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use |
| 09/30/2004 | WO2004043286A3 Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen |
| 09/30/2004 | WO2004042033A3 Circulating stem cells and uses related thereto |
| 09/30/2004 | WO2004038636A3 Tool for in vitro-in vivo correlation |
| 09/30/2004 | WO2004038405A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 09/30/2004 | WO2004038377A3 Method for diagnosing renal diseases or predispositions |
| 09/30/2004 | WO2004035009A3 Methods and systems to identify operational reaction pathways |
| 09/30/2004 | WO2004032842A3 Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers |
| 09/30/2004 | WO2004032716A3 Compounds for modulation of cholesterol transport |
| 09/30/2004 | WO2004031411A3 Genes and polypeptides relating to human pancreatic cancers |
| 09/30/2004 | WO2004031344A3 Characterizing nucleic acid and amino acid sequences in silico |